DMD and muscular dystrophy: In the latter case, implementation builds on a prospective consented pilot begun in 2019 that was aimed at addition of DMD to the RUSP and was developed in collaboration with expert partners interested in muscular dystrophies and NBS (Duchenne NBS Consortium).